Drug
Aspirin
Aspirin: highest development phase Post-Market, developed by Bausch Health, Otsuka, Teva. 3 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Bausch Health, Otsuka, Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| aspirin NCT01995370 | Post-Market | Noncardioembolic Cerebral Infarction |
| NORGESIC FORTE | Approved | |
| ASPIRIN; OMEPRAZOLE | Approved |
Latest
No recent events.
Follow Aspirin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.